Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Run-Zao Zhi-Yang Capsule in mild to moderate plaque psoriasis with intestinal microflora evaluation
ChiCTR1800019040Phase 4Not yet recruiting
- Sponsor
- Shanghai Skin Disease Hospital
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of runzao zhiyang capsule in plaque psoriasis and atopic dermatitis (AD) (2 arms), sponsored by Shanghai Skin Disease Hospital. Primary endpoints: Psoriasis Area and Severity Index, SCORAD and 1 more. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
runzao zhiyang capsule
03
Conditions
plaque psoriasisatopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR1800019040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019040.